A second participant in the AstraZeneca vaccine trials suffers from an unexplained neurological disorder

Parisians leave the city before the quarantine enters into force. The queues of cars stretched for miles

The queues of cars stretched for hundreds of kilometers on Thursday evening in the Ile-de-France region, according to the French press, writes BBC. Congestion...

‘Man arrested who may have had contact with attacker Nice’

French authorities arrested a 47-year-old man on Thursday evening in the investigation of the Nice attack. He is said to have been in...

The Nice terrorist had landed in Italy in September from Tunisia

The terrorist Brahim Aoussaoui, 21, that Thursday slaughtered two people and decapitated to a third in the nice cathedral, came to Europe disembarking...

Three perspectives: That is why Finns should also be interested in the US presidential election

The U.S. presidential election reads the state of the world’s leading state almost breathtakingly. On Nov. 3, it becomes clear whether the Western...

Jorgito, the premature baby who has overcome the coronavirus after four months hospitalized

After four months struggling between life and death at the Edgardo Rebagliati National Hospital in Peru, Jorgito is finally in his mother's arms. ...

The pharmaceutical AstraZeneca, which is developing a possible vaccine against Covid-19 together with the University of Oxford, has once again warned about worrying consequences in another volunteer.

This person has shown “unexplained neurological symptoms” in the third phase of the trials, as reported The New York Times.

This trial was halted a few days ago due to another mishap with a volunteer, who developed transverse myelitis. The company wanted to emphasize that these health problems have nothing to do with the vaccine in either case, as they have verified in a “independent review”.

“It has been considered unlikely that these diseases are associated with the vaccine, or that there was insufficient evidence to say with certainty that the diseases were related to the vaccine or not, “they say.

Experts are showing concern about a possible lack of communication between the 18,000 volunteers that have been provided to carry out the clinical trials and the company, alerting them of the diseases that these cases were contracting.

Therefore, the company has assured its intention to increase transparency about your research.



Related Articles